Obesity Reduction (GLP-1, GIP, & Fat Loss)

Explore research peptides studied for their potential role in weight management and metabolic health. GLP-1 and GIP receptor agonists have been investigated for their ability to regulate appetite, improve insulin sensitivity, and support fat loss. Other fat loss compounds may promote lipolysis, metabolic function, and body composition improvements. Peptides like semaglutide and compounds like tesofensine are of clinical interest for their roles in appetite suppression, neuronal activity modulation, and perhaps even for increasing resting energy expenditure for the purposes of fat loss. We also carry other experimental peptides such as retatrutide. These peptides are of interest to researchers studying obesity reduction and weight control mechanisms. **For research use only.**

**Register for a FREE account to unlock access to additional GLP-1s not available to guests!**